Related content

Phase II study with fractionated schedule of docetaxel and cisplatin in patients with advanced non-small cell lung cancer

By Kwon Jung   Kim Jung   Lee Jung-Ae   Shin Hyun   Kim Hyo   Song Hun   Jung Joo   Kim Ho   Choi Dae   Kim Hyeong   Park Young-iee   Zang Dae  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 5, 2010-10 ,pp. : 889-897

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of weekly paclitaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer

By Kallab Andre   Nalamolu Yasolatha   Dainer Paul   Jillella Anand  

Medical Oncology, Vol. 22, Iss. 2, 2005-06 ,pp. : 145-151

Humana Press, Inc

Access to resources Recommend Favorite

Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer

By Kalmadi Sujith   McNeill Giles   Davis Mellar   Peereboom David   Adelstein David   Mekhail Tarek  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 507-513

Humana Press, Inc

Access to resources Recommend Favorite

Weekly chemotherapy with carboplatin, docetaxel and irinotecan in advanced non-small-cell-lung cancer - a phase II study

By Pectasides D.   Visvikis A.   Kouloubinis A.   Glotsos J.   Bountouroglou N.   Karvounis N.   Ziras N.   Athanassiou A.  

European Journal of Cancer, Vol. 38, Iss. 9, 2002-06 ,pp. : 1194-1200

Elsevier

Access to resources Recommend Favorite

Carboplatin and docetaxel in advanced non-small-cell lung cancer: results of a multicenter phase II study

By Ramalingam Sakkaraiappan   Dobbs Tracy   Einzig Avi   Wojtowicz-Praga Slawomir   Cascino Marianne   Bonomi Phillip   Belani Chandra  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 5, 2004-05 ,pp. : 439-444

Springer Publishing Company

Access to resources Recommend Favorite